Compendium of pharmaceuticals and specialties cps
CPS: COMPENDIUM OF PHARMACEUTICALS & SPECIALTIES 2 VOLUME SET (ENGLISH) 2018 by Canadian Pharmacists AssociationDescription: The Compendium of Pharmaceuticals and Specialties (CPS) is the Canadian standard for drug monographs, developed by manufacturers, approved by Health Canada and optimized by CPhA editors. The CPS contains thousands of product monographs for drugs, vaccines and natural health products, including 65 NEW products for the Canadian market. This definitive resource also includes monographs written by Canadian Pharmacists Associations editorial staff, based on the best available evidence and reviewed by expert physicians and pharmacists. Clinical tools, product images (exclusive to CPS online) and directories of drug and health care information are included.
Information available across multiple platforms for health care professionals
It contains more than product monographs for drugs, vaccines and natural health products, including new products for the Canadian market. This definitive resource also has monographs written by the editorial staff of CPhA, based on the best available evidence and reviewed by expert physicians and pharmacists. Clinical tools, product images and directories of sources for drug and health care information are included. A comprehensive cross-referenced index of generic and brand names ensures you can easily find what you're looking for. The product monographs are prepared by the pharmaceutical manufacturers and approved by Health Canada. Convert currency.
Goodreads helps you keep track of books you want to read. Want to Read saving…. Want to Read Currently Reading Read. Other editions. Enlarge cover.
Health care practitioners and administrators face multiple challenges when it comes to staying current with therapeutic information. Not only does the information have to be accurate, reliable and up-to-date, it must also be easily accessible, available on a variety of high and low-tech platforms. The Canadian Pharmacists Association CPhA offers a suite of comprehensive drug and therapeutic resources, from the printed Compendium of Pharmaceuticals and Specialties CPS to an ever-growing list of electronic and mobile tools. Currently, the terminals are used during more than 4,, patient visits each year across the country. The CPS—a staple in virtually every health care office in Canada— is well known for its wealth of information on more than products, CPhA-authored monographs, product images and Therapeutic Guide. While close to 80 per cent of prescribing physicians already have access to CPS or its electronic version, e-CPS, at the point of care, the iMD offering expands its reach even further.
The Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals , more commonly known by its abbreviation CPS ,  is a reference book that contains drug monographs and numerous features which help healthcare professionals prescribe and use drugs safely and appropriately. The CPhA is a nonprofit organization that advocates for pharmacists in Canada.
mythological stories in sanskrit with translation in english
Easy Health Boost With Immunocal
The Compendium of Pharmaceuticals and Specialties CPS is the most widely used source of drug information in Canada, and is heavily financed by the pharmaceutical industry. A close examination of its contents comparing a computer-drawn, randomized sample of monographs from its "White Pages" to standard pharmacological reference works demonstrates certain of its characteristics: it uncritically includes many inadequate preparations; it overstates the benefits and understates the adverse qualities of many preparations; and it contains little or no information on relative indications, efficacy, or price. These characteristics serve to promote the marketing goals of the drug manufacturers and severely limit the volume's usefulness as an objective source of drug information. The role of the CPS and similar publications in the overall context of current drug company marketing strategies is discussed. Finally, suggestions for improvements are made involving the elimination of direct manufacturer financing, and the creation of an objective, independent, nonprofit publishing agency supported by professional and governmental organizations.